Montelukast out-of-pocket cost in the U.S. 2004-2021
In 2021, the average out-of-pocket cost for montelukast in the United States stood at 6.16 dollars. Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. This statistic shows the out-of-pocket cost of montelukast in the U.S. from 2004 to 2021.